WaratekVRT Sign in
Reset
More filters (1)
Columns
Including CVEs outside Waratek scope✕Product pharmaceutical✕
Overview 2 matches · 1 in Waratek scope · 0 protected · 0 exploited · 0 CISA KEV · 0 public PoC · 0 EPSS ≥ 0.5
2matches 1in Waratek scope50.0% 0protected0.0% 0exploited0.0% 0CISA KEV0.0% 0public PoC0.0% 0EPSS ≥ 0.50.0%
Protected by Waratek 0 0.0% Rule in development 0 0.0% Mitigation candidate 0 0.0% No exploit published 1 50.0% Outside Waratek scope 0 0.0% Not applicable 1 50.0% Withdrawn CVE 0 0.0%
Critical 0 0.0% High 2 100.0% Medium 0 0.0% Low 0 0.0% None 0 0.0% Unknown 0 0.0%
blocked by ARMR today 0 0.0% partly blocked 0 0.0% not blocked 2 100.0% not established 0 0.0% unrecorded 0 0.0%
Exploited 0 0.0% Working exploit published 0 0.0% Proof of concept only 0 0.0% Forecast only 0 0.0% No public exploit 2 100.0%
split by peak 1 / month
Apr 06May 06Jun 06Jul 06Aug 06Sep 06Oct 06
2 matches Sign in to download these CVEs as CSV or JSON, or to follow them in a feed.
CVE Severity Published▾ Status Exploitation Description
CVE-2006-5374 High 2006-10-18 Not applicable No public exploit Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.
CVE-2006-1884 High 2006-04-20 No exploit published No public exploit Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle E-Business Suite and OPA 4.5.2 Applications has unknown impact and attack vectors, aka Vuln# OPA01.